Pharmac funds second-line treatment for macular degeneration

+News

Pharmac funds second-line treatment for macular degeneration

Eylea
Pharmac will subsidise Eylea at $1250 per 40mg vial pack
Pharmac has funded a drug that will broaden treatment option